Boston Private Wealth LLC trimmed its position in Cigna Corp (NYSE:CI) by 12.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,625 shares of the health services provider’s stock after selling 981 shares during the period. Boston Private Wealth LLC’s holdings in Cigna were worth $1,006,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in CI. Alpine Woods Capital Investors LLC boosted its holdings in Cigna by 99.9% in the third quarter. Alpine Woods Capital Investors LLC now owns 31,199 shares of the health services provider’s stock valued at $4,825,000 after purchasing an additional 15,590 shares during the last quarter. Mutual Advisors LLC boosted its holdings in Cigna by 8.6% in the third quarter. Mutual Advisors LLC now owns 3,021 shares of the health services provider’s stock valued at $459,000 after purchasing an additional 240 shares during the last quarter. Coronation Fund Managers Ltd. boosted its holdings in Cigna by 11.6% in the third quarter. Coronation Fund Managers Ltd. now owns 37,585 shares of the health services provider’s stock valued at $5,705,000 after purchasing an additional 3,921 shares during the last quarter. Mackay Shields LLC boosted its stake in shares of Cigna by 12.3% during the 3rd quarter. Mackay Shields LLC now owns 80,039 shares of the health services provider’s stock worth $12,149,000 after acquiring an additional 8,743 shares in the last quarter. Finally, Gamco Investors INC. ET AL boosted its stake in shares of Cigna by 64.4% during the 3rd quarter. Gamco Investors INC. ET AL now owns 27,877 shares of the health services provider’s stock worth $4,231,000 after acquiring an additional 10,918 shares in the last quarter. 87.40% of the stock is currently owned by hedge funds and other institutional investors.

Several equities research analysts have recently issued reports on CI shares. Stephens set a $225.00 target price on shares of Cigna and gave the stock a “buy” rating in a research note on Friday, August 23rd. Deutsche Bank set a $210.00 target price on shares of Cigna and gave the stock a “buy” rating in a research note on Friday, November 1st. UBS Group increased their target price on shares of Cigna from $214.00 to $222.00 and gave the stock a “buy” rating in a research note on Tuesday. Morgan Stanley increased their target price on shares of Cigna from $207.00 to $208.00 and gave the stock an “overweight” rating in a research note on Thursday, September 26th. Finally, Oppenheimer set a $254.00 target price on shares of Cigna and gave the stock a “buy” rating in a research note on Tuesday, September 10th. Three equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. The company currently has an average rating of “Buy” and a consensus target price of $213.84.

In related news, CEO David Cordani purchased 32,509 shares of the firm’s stock in a transaction that occurred on Monday, September 9th. The shares were purchased at an average cost of $155.17 per share, with a total value of $5,044,421.53. Company insiders own 0.80% of the company’s stock.

Shares of Cigna stock opened at $188.20 on Friday. The firm has a market capitalization of $67.91 billion, a PE ratio of 13.23, a P/E/G ratio of 0.92 and a beta of 0.72. Cigna Corp has a twelve month low of $141.95 and a twelve month high of $226.60. The firm’s 50-day moving average price is $163.40 and its 200 day moving average price is $160.81. The company has a current ratio of 0.63, a quick ratio of 0.63 and a debt-to-equity ratio of 0.76.

Cigna (NYSE:CI) last issued its quarterly earnings results on Thursday, October 31st. The health services provider reported $4.54 earnings per share for the quarter, beating the Zacks’ consensus estimate of $4.37 by $0.17. The firm had revenue of $35.83 billion for the quarter, compared to analyst estimates of $34.20 billion. Cigna had a net margin of 3.30% and a return on equity of 12.79%. Cigna’s quarterly revenue was up 213.1% compared to the same quarter last year. During the same period last year, the company posted $3.84 EPS. On average, sell-side analysts predict that Cigna Corp will post 16.93 EPS for the current fiscal year.

About Cigna

Cigna Corporation, a health service organization, provides insurance and related products and services in the United States and internationally. It operates through Integrated Medical, Health Services, International Markets, and Group Disability and Other segments. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health and vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to individual customers on and off the public exchanges.

See Also: What is intrinsic value?

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corp (NYSE:CI).

Institutional Ownership by Quarter for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.